Bridgeway Capital Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-105,800
| Closed | -$96.3K | – | 1209 |
|
|
2025
Q1 | $96.3K | Buy |
105,800
+29,600
| +39% | +$26.9K | ﹤0.01% | 1042 |
|
|
2024
Q4 | $211K | Sell |
76,200
-2,200
| -3% | -$6.09K | ﹤0.01% | 995 |
|
|
2024
Q3 | $410K | Buy |
+78,400
| New | +$410K | 0.01% | 909 |
|
|
2024
Q2 | – | Sell |
-17,800
| Closed | -$136K | – | 1304 |
|
|
2024
Q1 | $136K | Sell |
17,800
-34,000
| -66% | -$260K | ﹤0.01% | 1172 |
|
|
2023
Q4 | $221K | Sell |
51,800
-39,883
| -44% | -$170K | ﹤0.01% | 1115 |
|
|
2023
Q3 | $385K | Sell |
91,683
-24,917
| -21% | -$105K | 0.01% | 955 |
|
|
2023
Q2 | $649K | Sell |
116,600
-800
| -0.7% | -$4.46K | 0.02% | 841 |
|
|
2023
Q1 | $673K | Sell |
117,400
-16,000
| -12% | -$91.7K | 0.02% | 814 |
|
|
2022
Q4 | $140K | Hold |
133,400
| – | – | ﹤0.01% | 1163 |
|
|
2022
Q3 | $358K | Buy |
133,400
+46,000
| +53% | +$123K | 0.01% | 983 |
|
|
2022
Q2 | $417K | Buy |
87,400
+30,000
| +52% | +$143K | 0.01% | 925 |
|
|
2022
Q1 | $235K | Sell |
57,400
-20,000
| -26% | -$81.9K | ﹤0.01% | 1142 |
|
|
2021
Q4 | $528K | Buy |
+77,400
| New | +$528K | 0.01% | 969 |
|